Patents Assigned to International Partnership For Microbicides, Inc.
  • Combination therapy intravaginal rings
    Patent number: 11259956
    Abstract: The present invention provides improved intravaginal drug delivery devices, i.e., intravaginal rings, useful for the prophylactic administration of dapivirine in combination with either an antimicrobial compound or a contraceptive to a human. The present invention also provides methods of blocking DNA polymerization by an HIV reverse transcriptase enzyme, methods of preventing HIV infection in a female human, methods of treating HIV infection in a female human, methods of preventing unintended pregnancy in a female human, and methods of preparing intravaginal rings.
    Type: Grant
    Filed: October 9, 2018
    Date of Patent: March 1, 2022
    Assignee: International Partnership for Microbicides, Inc.
    Inventors: Brid Devlin, Jonathon Daryll Holt, Andrew Nathan Brimer, Jeremy Peter Nuttall, Karl Malcolm, Susan Margaret Fetherston, Peter John James Boyd
  • Combination therapy intravaginal rings
    Patent number: 10137031
    Abstract: The present invention provides improved intravaginal drug delivery devices, i.e., intravaginal rings, useful for the prophylactic administration of dapivirine in combination with either an antimicrobial compound or a contraceptive to a human. The present invention also provides methods of blocking DNA polymerization by an HIV reverse transcriptase enzyme, methods of preventing HIV infection in a female human, methods of treating HIV infection in a female human, methods of preventing unintended pregnancy in a female human, and methods of preparing intravaginal rings.
    Type: Grant
    Filed: November 13, 2014
    Date of Patent: November 27, 2018
    Assignee: International Partnership for Microbicides, Inc.
    Inventors: Brid Devlin, Jonathon Daryll Holt, Andrew Nathan Brimer, Jeremy Peter Nuttall, Karl Malcolm, Susan Margaret Fetherston, Peter John James Boyd
  • Topical antiviral formulations
    Patent number: 9283182
    Abstract: The present invention relates to formulations of nucleotide reverse transcriptase inhibitors (NRTIs), preferably [2-(6-Amino-purin-9-yl)-1-methyl-ethoxymethyl]-phosphonic acid (tenofovir, PMPA), or a physiologically functional derivative thereof, suitable for topical application and their use in the prevention of HIV infections.
    Type: Grant
    Filed: September 24, 2010
    Date of Patent: March 15, 2016
    Assignees: The CONRAD Program of the Eastern Virginia Medical School (“CONRAD”), International Partnership for Microbicides, Inc.
    Inventor: Terrence C. Dahl
  • Topical antiviral formulations
    Patent number: 9060933
    Abstract: The present invention relates to formulations of nucleotide reverse transcriptase inhibitors (NRTIs), preferably [2-(6-Amino-purin-9-yl)-1-methyl-ethoxymethyl]-phosphonic acid (tenofovir, PMPA), or a physiologically functional derivative thereof, suitable for topical application and their use in the prevention of HIV infections.
    Type: Grant
    Filed: September 29, 2010
    Date of Patent: June 23, 2015
    Assignees: The CONRAD Program of the Eastern Virginia Medical School (“CONRAD”), International Partnership for Microbicides, Inc.
    Inventor: Terrence C. Dahl
  • TOPICAL ANTIVIRAL FORMULATIONS
    Publication number: 20110132376
    Abstract: The present invention relates to formulations of nucleotide reverse transcriptase inhibitors (NRTIs), preferably [2-(6-Amino-purin-9-yl)-1-methyl-ethoxymethyl]-phosphonic acid (tenofovir, PMPA), or a physiologically functional derivative thereof, suitable for topical application and their use in the prevention of HIV infections.
    Type: Application
    Filed: September 29, 2010
    Publication date: June 9, 2011
    Applicants: Conrad, International Partnership for Microbicides, Inc.
    Inventor: Terrence C. Dahl
  • TOPICAL ANTIVIRAL FORMULATIONS
    Publication number: 20110120475
    Abstract: The present invention relates to formulations of nucleotide reverse transcriptase inhibitors (NRTIs), preferably [2-(6-Amino-purin-9-yl)-1-methyl-ethoxymethyl]-phosphonic acid (tenofovir, PMPA), or a physiologically functional derivative thereof, suitable for topical application and their use in the prevention of HIV infections.
    Type: Application
    Filed: September 24, 2010
    Publication date: May 26, 2011
    Applicants: Conrad, International Partnership for Microbicides, Inc.
    Inventor: Terrence C. Dahl
  • BIODEGRADABLE INTRAVAGINAL MEDICAL DEVICE FOR DELIVERY OF THERAPEUTICS
    Publication number: 20100316691
    Abstract: The present disclosure relates to biodegradable intravaginal rings for the delivery of therapeutic or prophylactic agent, inter alia, antiviral agents. The present disclosure further relates to biodegradable polyurethanes which will allow therapeutic/prophylactic agents to be released in a controlled manner that will not degrade when in use, but will degrade upon disposal.
    Type: Application
    Filed: January 22, 2008
    Publication date: December 16, 2010
    Applicants: University of Utah Research Foundation, International Partnership For Microbicides, Inc.
    Inventors: Patrick Kiser, Patrick Tresco, Mark Mitchnick, Kavita Gupta, Hyder Aliyar